➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Express Scripts
Harvard Business School

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Ondansetron Hydrochloride Preservative Free, and when can generic versions of Ondansetron Hydrochloride Preservative Free launch?

Ondansetron Hydrochloride Preservative Free is a drug marketed by Accord Hlthcare, Am Regent, Apotex Inc, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms Ltd, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira, Luitpold, Mylan Labs Ltd, Sandoz Inc, Sun Pharm Inds Ltd, Taro Pharms Ireland, Teva, West-ward Pharms Int, and Wockhardt. and is included in twenty NDAs.

The generic ingredient in ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the ondansetron hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Ondansetron Hydrochloride Preservative Free

A generic version of ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE was approved as ondansetron hydrochloride by TEVA on November 22nd, 2006.

  Start Trial

Summary for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Drug patent expirations by year for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
Recent Clinical Trials for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of PennsylvaniaPhase 3
Pontificia Universidade Catolica de Sao PauloPhase 4
Charles University, Czech RepublicPhase 4

See all ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE clinical trials

Pharmacology for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE

US Patents and Regulatory Information for ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 206845-001 Mar 10, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 077011-001 Dec 26, 2006 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 076972-001 Dec 26, 2006 AP RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 202600-001 Dec 21, 2012 AP RX No No   Start Trial   Start Trial   Start Trial
Luitpold ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 077387-001 Dec 26, 2006 DISCN No No   Start Trial   Start Trial   Start Trial
Wockhardt ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 077716-001 Dec 26, 2006 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 202253-001 Jul 19, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Boehringer Ingelheim
McKinsey
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.